Meanwhile, the cancer immunotherapy sector reached $137.70 billion in 2024 and is projected to hit $261.74 billion by 2033 as major pharmaceutical companies unveiled breakthrough ...
Andina Copper is pleased to announce the commencement of field exploration at the Cobrasco porphyry copper-molybdenum project. Cobrasco is located in the underexplored Chocó Copper Belt of the ...
AstraZeneca and Daiichi Sankyo are preparing regulatory filings that could make their HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the first ...
a good way of having different viewpoints and skills involved in a project provide staff with an opportunity to learn new skills from other members of the team which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback